GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pacira BioSciences Inc (FRA:82P) » Definitions » 3-Year EBITDA Growth Rate

Pacira BioSciences (FRA:82P) 3-Year EBITDA Growth Rate : 26.90% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Pacira BioSciences 3-Year EBITDA Growth Rate?

Pacira BioSciences's EBITDA per Share for the three months ended in Dec. 2023 was €0.73.

During the past 12 months, Pacira BioSciences's average EBITDA Per Share Growth Rate was -1.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 26.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 38.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Pacira BioSciences was 70.20% per year. The lowest was -12.20% per year. And the median was 38.75% per year.


Competitive Comparison of Pacira BioSciences's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Pacira BioSciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacira BioSciences's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pacira BioSciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Pacira BioSciences's 3-Year EBITDA Growth Rate falls into.



Pacira BioSciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Pacira BioSciences  (FRA:82P) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Pacira BioSciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Pacira BioSciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacira BioSciences (FRA:82P) Business Description

Traded in Other Exchanges
Address
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Pacira BioSciences (FRA:82P) Headlines

No Headlines